Surgical Neurology
Volume 69, Issue 6 , Pages 561-567 , June 2008

Neuroprotective effects of Ac.YVAD.cmk on experimental spinal cord injury in rats

  • Alper Karaoğlan, MD

      Affiliations

    • Clinics of Neurosurgery, Taksim Education and Research Hospital, Istanbul, Turkey
    • ,
  • Ekrem Kaya, MD

      Affiliations

    • Clinics of Neurosurgery, Taksim Education and Research Hospital, Istanbul, Turkey
    • ,
  • Osman Akdemir, MD

      Affiliations

    • Clinics of Neurosurgery, Taksim Education and Research Hospital, Istanbul, Turkey
    • ,
  • Ayhan Sağmanligil, MD

      Affiliations

    • Clinics of Neurosurgery, Taksim Education and Research Hospital, Istanbul, Turkey
    • ,
  • Kaya Bilguvar, MD

      Affiliations

    • Department of Medical Biology, Marmara University School of Medicine, Istanbul, Turkey
    • ,
  • Beyazıt Çirakoğlu, PhD

      Affiliations

    • Department of Medical Biology, Marmara University School of Medicine, Istanbul, Turkey
    • ,
  • Elife Şahan, MD

      Affiliations

    • Clinics of Pathology, Taksim Education and Research Hospital, Istanbul, Turkey
    • ,
  • Nusret Erdoğan, MD

      Affiliations

    • Clinics of Pathology, Taksim Education and Research Hospital, Istanbul, Turkey
    • ,
  • Şeref Barut, MD

      Affiliations

    • Clinics of Neurosurgery, Taksim Education and Research Hospital, Istanbul, Turkey
    • ,
  • Ahmet Çolak, MD

      Affiliations

    • Clinics of Neurosurgery, Taksim Education and Research Hospital, Istanbul, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 212 2928261; fax: +90 212 2526300.

Received 12 January 2007 ,Accepted 12 March 2007.

References 

  1. Ahn YH, Lee G, Kang SK. Molecular insights of the injured lesions of rat spinal cords: inflammation, apoptosis, and cell survival. Biochem Biophys Res Commun. 2006;22:560–570
  2. Allen AR. Remarks on the histopathological changes in the spinal cord due to impact. An experimental study. J Nerv Ment Dis. 1914;41:141–147
  3. Azari MF, Profyris C, Karnezis T, et al. Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J Neuropathol Exp Neurol. 2006;65:914–929
  4. Barut S, Unlu YA, Karaoglan A, et al. The neuroprotective effects of z-DEVD.fmk, a caspase 3 inhibitor on traumatic spinal cord injury in rats. Surg Neurol. 2005;64:213–220
  5. Bresnahan JC, Schuman SL, Beattie MS. Evidence for apoptosis of oligodendroglia in long tracts undergoing wallerian degeneration after spinal cord injury (SCI) in monkeys. Soc Neurosci Abstr. 1996;22:1185
  6. Casha S, Yu WR, Fehlings MG. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience. 2001;103:203–218
  7. Cid C, Alvarez-Cermeno JC, Regidor I, et al. Caspase inhibitors protect against neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients. J Neuroimmunol. 2003;136:119–124
  8. Colak A, Karaoglan A, Barut S, et al. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. J Neurosurg Spine. 2005;2:327–334
  9. Crowe MJ, Bresnahan JC, Shuman SL, et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med. 1997;3:73–76
  10. Deveraux QL, Stennicke HR, Salvesen GS, et al. Endogenous inhibitors of caspases. J Clin Immunol. 1999;19:388–398
  11. Dinarello CA. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci. 1998;856:1–11
  12. Ekert PG, Silke J, Vaux DL. Caspase inhibitors. Cell Death Differ. 1999;6:1081–1086
  13. Emery E, Aldana P, Bunge MB, et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg. 1998;89:911–920
  14. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 1995;375:78–81
  15. Fink KB, Andrews LJ, Butler WE, et al. Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neurosci. 1999;94:1213–1218
  16. Friedlander RM, Brown RH, Gagliardini V, et al. Inhibition of ICE slows ALS in mice. Nature. 1997;388:31
  17. Friedlander RM, Juan J. ICE, neuronal apoptosis and neurodegeneration. Cell Death Differ. 1998;5:823–831
  18. Fiedlander RM, Gagliardini V, Rotello RJ, et al. Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta-converting enzyme–mediated apoptosis. J Exp Med. 1996;184:717–724
  19. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493–501
  20. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1312
  21. Hara H, Friedlander RM, Gagliardini V. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci U S A. 1997;94:2007–2012
  22. Hayashi Y, Jikihara I, Yagi T, et al. Immunohistochemical investigation of caspase-1 and effect of caspase-1 inhibitor in delayed neuronal death after transient cerebral ischemia. Brain Res. 2001;893:113–120
  23. Katoh K, Ikata T, Katoh S, et al. Induction and its spread of apoptosis in rat spinal cord after mechanical trauma. Neurosci Lett. 1996;216:9–12
  24. Kato H, Kanellopoulos GK, Matsuo S, et al. Neuronal apoptosis and necrosis following spinal cord ischemia in the rat. Exp Neurol. 1997;148:464–474
  25. Keane RW, Kraydieh S, Lotocki G, et al. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol. 2001;60:422–429
  26. Kerr JFR, Wyllie AH, Currie AR. Apoptosis. A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257
  27. Kostura MJ, Tocci MJ, Limjuco G, et al. Identification of a monocyte specific pre-interleukin-1 beta convertase activity. Proc Natl Acad Sci U S A. 1989;86:5227–5231
  28. Kuida K, Lippke JA, Ku G, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 1995;267:2000–2003
  29. Li GL, Brodin G, Farooque M, et al. Apoptosis and expression of Bcl-2 after compression trauma to the rat spinal cord. J Neuropathol Exp Neurol. 1996;55:280–289
  30. Li H, Colbourne F, Sun P, et al. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke. 2000;31:176–182
  31. Li M, Ona VO, Chen M, et al. Functional role and therapeutic implications of neuronal caspase-1 and 3 in a mouse model of traumatic spinal cord injury. Neuroscience. 2000;99:333–342
  32. Liu XZ, Xu XM, Hu R, et al. Neuronal and glial apoptosis after spinal cord injury. J Neurosci. 1997;17:5395–5406
  33. Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1996;16:932–940
  34. Lou J, Lenke LG, Ludwig FJ, et al. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord. 1998;36:683–690
  35. Lu J, Aswell KWS, Waite P. Advances in secondary spinal cord injury: role of apoptosis. Spine. 2000;25:1859–1866
  36. Quagliarello VJ, Wispelwey B, Long WJ, et al. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in rat. J Clin Invest. 1991;87:1360–1366
  37. Nicholson DW. From bench to clinic with apoptosis based therapeutic agents. Nature. 2000;407:810–816
  38. Okuda Y, Sakoda S, Fujimura H, et al. The effect of apoptosis inhibitors on autoimmune encephalomyelitis: apoptosis as a regulatory factor. Biochem Biophys Res Comm. 2000;267:826–830
  39. Raff M. Cell suicide for beginners. Nature. 1998;396:119–122
  40. Ray AM, Owen DE, Evans ML, et al. Caspase inhibitors are functionally neuroprotective against oxygen glucose deprivation induced CA1 death in rat organotypic hippocampal slides. Brain Res. 2000;867:62–69
  41. Rink A, Fung KM, Trajanowski JQ, et al. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol. 1995;147:1575–1583
  42. Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg. 1977;47:577–581
  43. Rudel T. Caspase inhibitors in prevention of apoptosis. Herz. 1999;24:236–241
  44. Samali A, Zhivotovsky B, Jones D, et al. Apoptosis: cell death defined by caspase activation. Cell Death Differ. 1999;6:495–496
  45. Springer JE, Azbill RD, Knapp PE. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med. 1999;5:943–946
  46. Tarlov IM. In: Spinal cord compression mechanism of paralysis and treatment. Springfield (Ill): Charles C Thomas; 1957;p. 147
  47. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995;81:801–809
  48. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456–1462
  49. Troy CM, Stefanis L, Prochiantz A, et al. The contrasting roles of ICE family proteases and interleukin-1 beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc Natl Acad Sci U S A. 1996;93:5635–5640
  50. Van de Craen M, Van Loo G, Pype S. Identification of a new caspase homologue: caspase-14. Cell Death Diff. 1998;5:838–846
  51. Villa P, Kaufmann SH, Earnshow WC. Caspases and caspase inhibitors. Trends Biochem Sci. 1997;22:388–393

PII: S0090-3019(07)00448-X

doi: 10.1016/j.surneu.2007.03.041

Surgical Neurology
Volume 69, Issue 6 , Pages 561-567 , June 2008

Article Tools

* Image Usage & Resolution